Evidence map›Paper›PMID 26885667›Full record

ArticlePloS one2016

Activation of the Nrf2 Cell Defense Pathway by Ancient Foods: Disease Prevention by Important Molecules and Microbes Lost from the Modern Western Diet.

Donald R Senger, Dan Li, Shou-Ching Jaminet, Shugeng Cao

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07383701 (Lactiplantibacillus Plantarum 299v Probiotic Probiotic Supplementation in Patients With Diabetic Macular Edema), which is not on this map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07383701 phase2not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Lactiplantibacillus Plantarum 299v Probiotic Probiotic Supplementation in Patients With Diabetic Macular Edema

TypeinterventionalSponsorMassachusetts Eye and Ear InfirmaryRan2026 to 2027Enrolled36ConditionsDiabetic Macular EdemaArmsLactobacillus plantarum 299v
3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 117 citations in OpenAlex.

  1. FermentedNutrients · 2022
    Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. 2,5-Dihydroxyphenylethanone: an anti-melanogenic bioactive compound isolated fromJournal of enzyme inhibition and medicinal chemistry · 2025
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Fermented foods and gastrointestinal health: underlying mechanisms.Nature reviews. Gastroenterology & hepatology · 2024
    Review
  15. Food Polyphenols as Preventive Medicine.Antioxidants (Basel, Switzerland) · 2023
    Review
  16. Review
  17. A normative microbiome is not restored following kidney transplantation.Clinical science (London, England : 1979) · 2023
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Donald R SengerDepartment of Pathology and Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
Dan LiDepartment of Pathology and Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
Shou-Ching JaminetDepartment of Pathology and Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
Shugeng CaoDepartment of Pharmaceutical Sciences, Daniel K. Inouye College of Pharmacy, University of Hawaii at Hilo, Hilo, Hawaii, United States of America.
Beth Israel Deaconess Medical Center · USCenter for Vascular Biology Research · USUniversity of Hawaii at Hilo · US

Funding

Remedying dysfunctional angiogenesis and tissue ischemia with Barleria lupulinaR01AT007022 · NCCIH · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SENGER, DONALD R · 2012 to 2015
$1.9M
NCCIH NIH HHS R01 AT007022NCCIH NIH HHS R01AT007022
6 · The paper itself

Abstract

The Nrf2 (NFE2L2) cell defense pathway protects against oxidative stress and disorders including cancer and neurodegeneration. Although activated modestly by oxidative stress alone, robust activation of the Nrf2 defense mechanism requires the additional presence of co-factors that facilitate electron exchange. Various molecules exhibit this co-factor function, including sulforaphane from cruciferous vegetables. However, natural co-factors that are potent and widely available from dietary sources have not been identified previously. The objectives of this study were to investigate support of the Nrf2 cell defense pathway by the alkyl catechols: 4-methylcatechol, 4-vinylcatechol, and 4-ethylcatechol. These small electrochemicals are naturally available from numerous sources but have not received attention. Findings reported here illustrate that these compounds are indeed potent co-factors for activation of the Nrf2 pathway both in vitro and in vivo. Each strongly supports expression of Nrf2 target genes in a variety of human cell types; and, in addition, 4-ethylcatechol is orally active in mice. Furthermore, findings reported here identify important and previously unrecognized sources of these compounds, arising from biotransformation of common plant compounds by lactobacilli that express phenolic acid decarboxylase. Thus, for example, Lactobacillus plantarum, Lactobacillus brevis, and Lactobacillus collinoides, which are consumed from a diet rich in traditionally fermented foods and beverages, convert common phenolic acids found in fruits and vegetables to 4-vinylcatechol and/or 4-ethylcatechol. In addition, all of the alkyl catechols are found in wood smoke that was used widely for food preservation. Thus, the potentially numerous sources of alkyl catechols in traditional foods suggest that these co-factors were common in ancient diets. However, with radical changes in food preservation, alkyl catechols have been lost from modern foods. The absence of alkyl catechols from the modern Western diet suggests serious negative consequences for Nrf2 cell defense, resulting in reduced protection against multiple chronic diseases associated with oxidative stress.

Indexed as

Diet, WesternFoodAnimalsBacteriaBiotransformationBlotting, WesternCaffeic AcidsCarboxy-LyasesCatecholsCells, CulturedChlorogenic AcidGene Expression RegulationHeme Oxygenase-1HumansHuman Umbilical Vein Endothelial CellsHydroxybenzoatescaffeic acidCaffeic AcidsCarboxy-LyasesCatecholsChlorogenic AcidHeme Oxygenase-1HydroxybenzoatesIsothiocyanatesNF-E2-Related Factor 2Oxygenphenolic acid decarboxylaseprotocatechuic acidRNA, MessengerRNA, Small InterferingsulforaphaneSulfoxides

Identifiers

PMID26885667
PMCPMC4757558
OpenAlexW2278050465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.